# German Preoperative Adriamycin Docetaxel Study

> **NCT00543829** · PHASE2 · COMPLETED · sponsor: **GBG Forschungs GmbH** · enrollment: 250 (actual)

## Conditions studied

- Breast Neoplasms

## Interventions

- **DRUG:** doxorubicin, docetaxel, tamoxifen
- **DRUG:** doxorubicin, docetaxel

## Key facts

- **NCT ID:** NCT00543829
- **Lead sponsor:** GBG Forschungs GmbH
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-04
- **Primary completion:** —
- **Final completion:** 1999-06
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2007-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00543829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00543829, "German Preoperative Adriamycin Docetaxel Study". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00543829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*